Metropolis Healthcare Faces Financial Pressures Despite Sales Growth and Low Debt Levels
Metropolis Healthcare has recently experienced an evaluation adjustment reflecting changes in its financial metrics. For the quarter ending June 2025, the company reported flat performance with net sales of Rs 386.06 crore and a profit before tax of Rs 53.71 crore, alongside a low debt-equity ratio of 0.15 times.
Metropolis Healthcare, a small-cap player in the healthcare services industry, has recently undergone an evaluation adjustment that reflects a shift in its financial metrics. The company's financial performance for the quarter ending June 2025 has been characterized as flat, with notable figures such as net sales reaching Rs 386.06 crore and a profit before tax (PBT) of Rs 53.71 crore, which has shown growth compared to previous quarters. Additionally, the profit after tax (PAT) stands at Rs 45.06 crore, also reflecting an upward trend relative to past averages.On the balance sheet, Metropolis Healthcare maintains a low debt-equity ratio of 0.15 times, indicating a conservative approach to leverage. However, certain metrics such as return on capital employed (ROCE) and cash reserves are at lower levels, which may raise concerns about operational efficiency and liquidity. The company's debtor turnover ratio is also on the lower side at 9.00 times, suggesting potential challenges in receivables management.
Overall, the recent evaluation adjustment highlights a complex picture for Metropolis Healthcare, balancing strong sales growth against some underlying financial pressures.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
